A method for determining isomers of tenofovir alafenamide

CN114137092BActive Publication Date: 2025-02-11BEIJING SIHUAN PHARMA +1
View PDF -1 Cites 0 Cited by

Patent Information

Application Number
CN202010916951.9
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2020-09-03
Publication Date
2025-02-11
Estimated Expiration
2040-09-03
Patent Text Reader

Abstract

The present invention provides a method for determining the isomers of tenofovir alafenamide by high performance liquid chromatography, wherein the high performance liquid chromatography conditions are: using chiral C 18 The reversed-phase silica gel column has a detection wavelength of 260 nm, a flow rate of 0.1-1.0 ml / min, a column temperature of 20-40 ° C, an injection volume of 5-50 μl, and a mobile phase consisting of phase A and phase B; wherein the phase A is an organic solvent, the phase B is an aqueous solution at pH 6-9, and the volume ratio of the phase A to the phase B is 10:90-50:50. The present invention adopts a chiral C 18 The reversed-phase silica gel chromatography column is used for high performance liquid chromatography detection of the difficult-to-separate corresponding isomeric impurities of tenofovir alafenamide. It has low equipment requirements, high versatility, low cost, and is suitable for large-scale industrial detection. At the same time, by optimizing the elution conditions, the corresponding isomeric impurity 1 and other diastereoisomers can be detected simultaneously, which simplifies the operation steps, reduces the detection frequency, saves detection time and cost, and greatly saves the cost of industrial quality control.
Need to check novelty before this filing date? Find Prior Art